This information is related to the use of simvastatin with amiodarone.
To report any serious adverse events associated with the use of these drugs, please contact the FDA MedWatch program using the contact information at the bottom of this page.
FDA Drug Safety Communication: Revised dose limitation for Zocor (simvastatin) when taken with amiodarone[ARCHIVED]
FDA Drug Safety Communication: New restrictions, contraindications, and dose limitations for Zocor (simvastatin) to reduce the risk of muscle injury[ARCHIVED]
FDA Drug Safety Communication: Ongoing safety review of high-dose Zocor (simvastatin) and increased risk of muscle injury[ARCHIVED]
Information for Healthcare Professionals: Simvastatin (marketed as Zocor and generics), Ezetimibe/Simvastatin (marketed as Vytorin), Niacin extended-release /Simvastatin (marketed as Simcor), used with Amiodarone (Cordarone, Pacerone)[ARCHIVED]
Ezetimibe/Simvastatin (marketed as Vytorin) Information Simvastatin Information
- Amiodarone (marketed as Cordarone and Pacerone) Information